PC
ALBO

PA Capital’s Albireo Pharma Inc ALBO Stock Holding History

PA Capital’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$268K Sell
8,044
-4,943
-38% -$144K 0.19% 144
2020
Q2 		$344K Sell
12,987
-10,211
-44% -$241K 0.25% 118
2020
Q1 		$380K Buy
23,198
+7,939
+52% +$175K 0.34% 107
2019
Q4 		$388K Sell
15,259
-239
-2% -$4.78K 0.34% 95
2019
Q3 		$310K Buy
15,498
+1,036
+7% +$26.8K 0.31% 98
2019
Q2 		$466K Sell
14,462
-736
-5% -$24.6K 0.42% 76
2019
Q1 		$490K Buy
15,198
+506
+3% +$13.6K 0.44% 70
2018
Q4 		$360K Buy
+14,692
New +$388K 0.38% 75

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

PA Capital's ALBO Position: Q3 2020 in Review

PA Capital reduced its Albireo Pharma Inc (ALBO) stake by 38% in Q3 2020, selling an estimated $144K and leaving 8,044 shares worth $268K. The position accounts for 0.19% of the portfolio, ranked #144.

PA Capital first reported a position in ALBO in Q4 2018 and has held it in 8 quarters since. The position peaked at $490K in Q1 2019. 108 funds tracked by Wall St. Rank hold ALBO as of Q3 2020.

  • PA Capital held 8,044 shares of Albireo Pharma Inc worth $268K as of Q3 2020.
  • PA Capital sold 4,943 Albireo Pharma Inc shares in Q3 2020, an estimated $144K.
  • Albireo Pharma Inc made up 0.19% of PA Capital's portfolio in Q3 2020, its #144 holding.
  • PA Capital first reported a position in Albireo Pharma Inc in Q4 2018 and has held it in 8 quarters since.
  • PA Capital's Albireo Pharma Inc position peaked at $490K in Q1 2019.
  • 108 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2020.

Based on PA Capital's 13F filing for Q3 2020, filed 13 Nov 2020.